logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Breast Cancer Metastasis And Drug Resistance Progress And Prospects 2013th Edition Springer

  • SKU: BELL-56091414
Breast Cancer Metastasis And Drug Resistance Progress And Prospects 2013th Edition Springer
$ 31.00 $ 45.00 (-31%)

4.7

16 reviews

Breast Cancer Metastasis And Drug Resistance Progress And Prospects 2013th Edition Springer instant download after payment.

Publisher: Springer
File Extension: PDF
File size: 5.5 MB
Pages: 416
Author: Springer
ISBN: 9781493901623, 1493901621
Language: English
Year: 2013
Edition: 2013

Product desciption

Breast Cancer Metastasis And Drug Resistance Progress And Prospects 2013th Edition Springer by Springer 9781493901623, 1493901621 instant download after payment.

​This volume comprehensively covers recent prrogress in breast cancer research. In an effort to successfully treat breast cancer, it is imperative to a) fully understand the disease with all its heterogeneity, b) understand the factors that influence the metastasis of breast cancer to distant organs making it lethal and c) understand the underlying processes that lead to the phenomenon of drug-resistance making the disease particularly incurable. The book explores all of these issues, including the phenomenon of epithelial-mesenchymal-transition, cancer stem cells as well as microRNAs in an attempt to better understand the disease in connection to its heterogeneity/metastasis/drug-resistance as well as to propose novel signaling pathways for therapeutic intervention. The profiling of tumors to molecularly classify breast cancers is also investigated so that customized targeted therapies can be developed. ​

Related Products